30 Jan 2024 --- FrieslandCampina Ingredients reveals it has received regulatory approval for its 2’-Fucosyllactose (2’-FL) human milk oligosaccharide (HMO) ingredient, Aequival 2’-FL, in Thailand. According to the company, the approval extends its use to infant milk and follow-up formulas, broadening the ingredient’s application in early life nutrition (ELN).
